ADAMTS5

A disintegrin and metalloproteinase with thrombospondin motifs 5 · Q9UNA0 · ADAMTS5 on Sugi Atlas →

42,326 patent compounds predicted against ADAMTS5, 25,124 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL610254 SCHEMBL610254 0.76 16/20
SCHEMBL607476 SCHEMBL607476 0.67 15/20
SCHEMBL609432 SCHEMBL609432 0.65 15/20
SCHEMBL611157 SCHEMBL611157 0.78 14/20
SCHEMBL610639 SCHEMBL610639 0.68 14/20
SCHEMBL610739 SCHEMBL610739 0.67 14/20
SCHEMBL610546 SCHEMBL610546 0.65 14/20
SCHEMBL608917 SCHEMBL608917 0.78 13/20
SCHEMBL610665 SCHEMBL610665 0.74 13/20
SCHEMBL607923 SCHEMBL607923 0.62 13/20
SCHEMBL762368 SCHEMBL762368 0.50 13/20
SCHEMBL762369 SCHEMBL762369 0.50 13/20
SCHEMBL855440 SCHEMBL855440 0.36 11/20
SCHEMBL610570 SCHEMBL610570 0.61 10/20
SCHEMBL609006 SCHEMBL609006 0.84 9/20
SCHEMBL609111 SCHEMBL609111 0.63 9/20
SCHEMBL207068 SCHEMBL207068 0.46 9/20
SCHEMBL855469 SCHEMBL855469 0.33 9/20
SCHEMBL14762 SCHEMBL14762 0.55 8/20
SCHEMBL205991 SCHEMBL205991 0.47 8/20

Clinical trials — most relevant to ADAMTS5 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura PHASE4WITHDRAWN
Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus. PHASE4COMPLETED
PRP in ACLR to Prevent PTOA PHASE3RECRUITING
Aspirin for Prophylaxis of TTP PHASE2/PHASE3NOT_YET_RECRUITING
A Study of AA4500 in Men With Peyronie's Disease PHASE3COMPLETED
Sputum Matrix Metalloproteinases (MMP) mRNA and Montelukast PHASE2COMPLETED
Synvisc to Treat Osteoarthritis of the Temporomandibular Joint PHASE2COMPLETED
The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP) PHASE2COMPLETED
Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP) PHASE1COMPLETED
The Role of Matrix Metalloproteinases (MMPs) in Orthodontic Tooth Movement PHASE1COMPLETED
ADAMTS-13 LEVEL AS PREDICTIVE BIOMARKER FOR DEVELOPMENT OF PORTAL VEIN THROMBOSIS IN LIVER CIRRHOSIS (ADAPTHRO) nanUNKNOWN
Role of A Disintegrin and Metalloproteinase (ADAM) in Epithelial Dysfunction nanCOMPLETED
Extracellular Matrix Remodeling of the Umbilical Cord and Placenta in Preeclampsia nanUNKNOWN
Evaluation of Different Serum Cartilage Biomarkers in the Acute Response to Walking and Cycling in Healthy Male Subjects nanAVAILABLE
ADAMTS13 in Thrombotic Thrombocytopenic Purpura nanCOMPLETED
Prognostic Indices of Atheromatosis Severity and Coronary Artery Bypass Surgery Outcomes for Patients With Coronary Artery Disease nanACTIVE_NOT_RECRUITING
Apoptotic Changes in Gingiva Caused by Smoking nanCOMPLETED
A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI) nanUNKNOWN
Screening of TMA Patients für ADAMTS13 Activity (Adamscreen) nanUNKNOWN
Elevated Plasma Levels of TIMP-1 in Patients With Rotator Cuff Tear nanCOMPLETED
Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer nanCOMPLETED
Matrix Metalloproteinases 7 and 9 in Rheumatoid Arthritis Patients With Interstitial Lung Disease nanNOT_YET_RECRUITING
Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence nanWITHDRAWN
Peri-implantitis and MMP-8 nanCOMPLETED
Association Between Matrix Metalloproteinase-2 Gene Polymorphism rs243865 and Susceptibility to Cataract Development nanCOMPLETED
Role of Extracellular Matrix in the Development of Airway Remodeling in Asthma nanUNKNOWN
LRP1 and Colon Cancer nanUNKNOWN
Biomarkers in Post Thrombotic Syndrome nanCOMPLETED
Re-evaluation of Some Old Rheumatoid Arthritis Therapy: A Randomized Controlled Trial nanCOMPLETED
Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ADAMTS5 binder may also engage these)

ProteinNameSimilarity
Q9R001 0.996 Q9R001 →
P97857 0.995 P97857 →
P59384 0.994 P59384 →
Q8TE58 0.994 Q8TE58 →
ADAMTS1 A disintegrin and metalloproteinase with thrombospondin motifs 1 0.994 landscape →
Q8WXS8 0.992 Q8WXS8 →
P59511 0.990 P59511 →
Q4VC17 0.990 Q4VC17 →
Q69Z28 0.989 Q69Z28 →
Q8TE57 0.988 Q8TE57 →
O95450 0.987 O95450 →
Q9WUQ1 0.987 Q9WUQ1 →
Q9H324 0.987 Q9H324 →
Q8TE60 0.986 Q8TE60 →
P58459 0.986 P58459 →
Q9TT93 0.985 Q9TT93 →
Q8C9W3 0.985 Q8C9W3 →
P79331 0.984 P79331 →
Q9P2N4 0.983 Q9P2N4 →
Q9ESP7 0.983 Q9ESP7 →
P57110 0.983 P57110 →
ADAMTS7 A disintegrin and metalloproteinase with thrombospondin motifs 7 0.983 landscape →
P59510 0.983 P59510 →
Q19791 0.982 Q19791 →
Q68SA9 0.982 Q68SA9 →
Q1EHB3 0.982 Q1EHB3 →
Q8BNJ2 0.982 Q8BNJ2 →
P19336 0.981 P19336 →
O15072 0.981 O15072 →
ADAMTS12 A disintegrin and metalloproteinase with thrombospondin motifs 12 0.981 landscape →